JAK2 and neoplasm: The activation of REG3A will enhance JAK2/STAT3 pathway, amplify the carcinogenic effect of IL-6/JAK2/STAT3, and ultimately leads to excessive PC cell proliferation in vitro and in vivo and tumor formation (5).